Literature DB >> 27043043

The "neuro" of neuroblastoma: Neuroblastoma as a neurodevelopmental disorder.

Nancy Ratner1, Garrett M Brodeur2, Russell C Dale3, Nina F Schor4.   

Abstract

Neuroblastoma is a childhood cancer derived from cells of neural crest origin. The hallmarks of its enigmatic character include its propensity for spontaneous regression under some circumstances and its association with paraneoplastic opsoclonus, myoclonus, and ataxia. The neurodevelopmental underpinnings of its origins may provide important clues for development of novel therapeutic and preventive agents for this frequently fatal malignancy and for the associated paraneoplastic syndromes. Ann Neurol 2016;80:13-23.
© 2016 American Neurological Association.

Entities:  

Mesh:

Year:  2016        PMID: 27043043      PMCID: PMC5419586          DOI: 10.1002/ana.24659

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  91 in total

Review 1.  On Trk--the TrkB signal transduction pathway is an increasingly important target in cancer biology.

Authors:  Carol J Thiele; Zhijie Li; Amy E McKee
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

2.  The genetics of splicing in neuroblastoma.

Authors:  Justin Chen; Christopher S Hackett; Shile Zhang; Young K Song; Robert J A Bell; Annette M Molinaro; David A Quigley; Allan Balmain; Jun S Song; Joseph F Costello; W Clay Gustafson; Terry Van Dyke; Pui-Yan Kwok; Javed Khan; William A Weiss
Journal:  Cancer Discov       Date:  2015-01-30       Impact factor: 39.397

3.  Cerebrospinal fluid oligoclonal bands in childhood opsoclonus-myoclonus.

Authors:  Michael R Pranzatelli; Patricia R Slev; Elizabeth D Tate; Anna L Travelstead; Jerry A Colliver; Suja Anne Joseph
Journal:  Pediatr Neurol       Date:  2011-07       Impact factor: 3.372

4.  Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications.

Authors:  Lizzia Raffaghello; Ignazia Prigione; Paola Bocca; Fabio Morandi; Marta Camoriano; Claudio Gambini; Xinhui Wang; Soldano Ferrone; Vito Pistoia
Journal:  Oncogene       Date:  2005-07-07       Impact factor: 9.867

5.  Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.

Authors:  E Rudnick; Y Khakoo; N L Antunes; R C Seeger; G M Brodeur; H Shimada; R B Gerbing; D O Stram; K K Matthay
Journal:  Med Pediatr Oncol       Date:  2001-06

6.  TrkA as a life and death receptor: receptor dose as a mediator of function.

Authors:  Chaohua Yan; Ye Liang; Karen D Nylander; Nina Felice Schor
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

Review 7.  Engineering anti-GD2 monoclonal antibodies for cancer immunotherapy.

Authors:  Mahiuddin Ahmed; Nai-Kong V Cheung
Journal:  FEBS Lett       Date:  2013-12-01       Impact factor: 4.124

8.  Bcl-2 mediates induction of neural differentiation.

Authors:  Ye Liang; Zeljka Korade Mirnics; Chaohua Yan; Karen D Nylander; Nina Felice Schor
Journal:  Oncogene       Date:  2003-08-21       Impact factor: 9.867

9.  A distinct gene expression signature characterizes human neuroblastoma cancer stem cells.

Authors:  Robert A Ross; Jeanette D Walton; Dan Han; Hong-Fen Guo; Nai-Kong V Cheung
Journal:  Stem Cell Res       Date:  2015-08-20       Impact factor: 2.020

10.  Expression of MYCN in Multipotent Sympathoadrenal Progenitors Induces Proliferation and Neural Differentiation, but Is Not Sufficient for Tumorigenesis.

Authors:  Bret C Mobley; Minjae Kwon; Bradley R Kraemer; F Edward Hickman; Jingbo Qiao; Dai H Chung; Bruce D Carter
Journal:  PLoS One       Date:  2015-07-29       Impact factor: 3.240

View more
  20 in total

1.  A Life at the Interface: The 2017 Hower Award Lecture.

Authors:  Nina F Schor
Journal:  Pediatr Neurol       Date:  2017-12-07       Impact factor: 3.372

2.  Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.

Authors:  Viviane Rösner Almeida; Igor Araujo Vieira; Marienela Buendia; André Tesainer Brunetto; Lauro J Gregianin; Algemir Lunardi Brunetto; Fábio Klamt; Caroline Brunetto de Farias; Ana Lucia Abujamra; Patrícia Luciana da Costa Lopez; Rafael Roesler
Journal:  Mol Neurobiol       Date:  2016-11-10       Impact factor: 5.590

3.  Preparation of CoS nanoparticles-cisplatin bio-conjugates and investigation of their effects on SH-SY5Y neuroblastoma cell line.

Authors:  Muhammed Sait Ertugrul; Hayrunnisa Nadaroglu; Ozge Balpinar Nalci; Ahmet Hacimuftuoglu; Azize Alayli
Journal:  Cytotechnology       Date:  2020-10-23       Impact factor: 2.058

4.  Comparative gene expression profiling of human metallothionein-3 up-regulation in neuroblastoma cells and its impact on susceptibility to cisplatin.

Authors:  Miguel Angel Merlos Rodrigo; Simona Dostalova; Hana Buchtelova; Vladislav Strmiska; Petr Michalek; Sona Krizkova; Ales Vicha; Pavla Jencova; Tomas Eckschlager; Marie Stiborova; Zbynek Heger; Vojtech Adam
Journal:  Oncotarget       Date:  2017-12-16

5.  Novel Src/Abl tyrosine kinase inhibitor bosutinib suppresses neuroblastoma growth via inhibiting Src/Abl signaling.

Authors:  Shayahati Bieerkehazhi; Zhenghu Chen; Yanling Zhao; Yang Yu; Huiyuan Zhang; Sanjeev A Vasudevan; Sarah E Woodfield; Ling Tao; Joanna S Yi; Jodi A Muscal; Jonathan C Pang; Shan Guan; Hong Zhang; Jed G Nuchtern; Hui Li; Huiwu Li; Jianhua Yang
Journal:  Oncotarget       Date:  2017-01-03

6.  Sequence-dependent trafficking and activity of GDE2, a GPI-specific phospholipase promoting neuronal differentiation.

Authors:  Fernando Salgado-Polo; Michiel van Veen; Bram van den Broek; Kees Jalink; Daniela Leyton-Puig; Anastassis Perrakis; Wouter H Moolenaar; Elisa Matas-Rico
Journal:  J Cell Sci       Date:  2020-02-10       Impact factor: 5.285

7.  Analysis of SARS-CoV-2 infection associated cell entry proteins ACE2, CD147, PPIA, and PPIB in datasets from non SARS-CoV-2 infected neuroblastoma patients, as potential prognostic and infection biomarkers in neuroblastoma.

Authors:  Brandon Bergsneider; Elise Bailey; Yusuf Ahmed; Namrata Gogineni; Derek Huntley; Ximena Montano
Journal:  Biochem Biophys Rep       Date:  2021-07-19

8.  The protective autophagy activated by GANT-61 in MYCN amplified neuroblastoma cells is mediated by PERK.

Authors:  Jing Wang; Siqi Huang; Ruicheng Tian; Jing Chen; Hongxiang Gao; Chenjie Xie; Yuhua Shan; Zhen Zhang; Song Gu; Min Xu
Journal:  Oncotarget       Date:  2018-01-13

Review 9.  Methylation of DNA and chromatin as a mechanism of oncogenesis and therapeutic target in neuroblastoma.

Authors:  Ram Mohan Ram Kumar; Nina Felice Schor
Journal:  Oncotarget       Date:  2018-04-24

10.  Expression of the Neuroblastoma-Associated ALK-F1174L Activating Mutation During Embryogenesis Impairs the Differentiation of Neural Crest Progenitors in Sympathetic Ganglia.

Authors:  Lucie Vivancos Stalin; Marco Gualandi; Johannes Hubertus Schulte; Raffaele Renella; Olga Shakhova; Annick Mühlethaler-Mottet
Journal:  Front Oncol       Date:  2019-04-16       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.